These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 884683)
21. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity. Prager MD; Granatek CH; Ludden CM Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692 [TBL] [Abstract][Full Text] [Related]
22. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226 [TBL] [Abstract][Full Text] [Related]
23. Role of immune mechanisms in metastatic patterns of hemopoietic tumors in rats. Ioachim HL; Pearse A; Keller SE Cancer Res; 1976 Aug; 36(8):2854-62. PubMed ID: 819134 [TBL] [Abstract][Full Text] [Related]
24. Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction. Glaser M; Herberman RB; Kirchner H; Djeu JY Cancer Res; 1974 Sep; 34(9):2165-71. PubMed ID: 4276482 [No Abstract] [Full Text] [Related]
25. Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice. Raz A; Barzilai R; Spira G; Inbar M Cancer Res; 1978 Aug; 38(8):2480-5. PubMed ID: 667843 [No Abstract] [Full Text] [Related]
26. Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma. Glaser M; Herberman R J Natl Cancer Inst; 1976 Jun; 56(6):1211-5. PubMed ID: 62841 [TBL] [Abstract][Full Text] [Related]
27. Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs. Bonmassar E; Testorelli C; Franco P; Goldin A; Cudkowicz G Cancer Res; 1975 Aug; 35(8):1957-62. PubMed ID: 1149019 [TBL] [Abstract][Full Text] [Related]
28. Complement-fixing soluble antigen from rat lymphoma (C58NT)D. Preliminary characterization of the antigen and some positive human sera. Chorváth B; Hlubinová K; Simkovic D Neoplasma; 1978; 25(3):279-83. PubMed ID: 79985 [TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
30. Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations. Oehler JR; Herberman RB J Natl Cancer Inst; 1979 Mar; 62(3):525-9. PubMed ID: 153984 [TBL] [Abstract][Full Text] [Related]
31. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. Hamaoka T; Shimizu J; Suda T; Fujiwara H Princess Takamatsu Symp; 1988; 19():265-75. PubMed ID: 3269360 [TBL] [Abstract][Full Text] [Related]
32. [Immunobiological characterization of murine LB leukemia and the LBC cell line]. Hajos SE; Mongini C; Waldner C; Sánchez Lockhart M; Gravisaco MJ; Roig I; Fernańdez T; Alvarez E Medicina (B Aires); 1996; 56 Suppl 1():45-56. PubMed ID: 9224974 [TBL] [Abstract][Full Text] [Related]
33. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. Bright RK; Shearer MH; Kennedy RC J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411 [TBL] [Abstract][Full Text] [Related]
34. Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response. Oren ME; Herberman RB; Canty TG J Natl Cancer Inst; 1971 Mar; 46(3):621-8. PubMed ID: 5547316 [No Abstract] [Full Text] [Related]
35. Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor. Garrido A; Pérez M; Delgado C; Garrido ML; Rojano J; Algarra I; Garrido F Exp Clin Immunogenet; 1986; 3(2):98-110. PubMed ID: 3274051 [TBL] [Abstract][Full Text] [Related]
36. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors. Sato N; Kikuchi K J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382 [TBL] [Abstract][Full Text] [Related]
37. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells. Ohnishi K; Bonavida B J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977 [TBL] [Abstract][Full Text] [Related]
38. Immunosuppression associated with SJL/J murine lymphoma. II. Characterization of a plasma suppressor factor in tumor-bearing mice. Kumar RK; Lykke AW; Penny R J Natl Cancer Inst; 1981 Dec; 67(6):1277-82. PubMed ID: 6947110 [TBL] [Abstract][Full Text] [Related]
39. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Hashimoto Y; Sugawara M; Masuko T; Hojo H Cancer Res; 1983 Nov; 43(11):5328-34. PubMed ID: 6616468 [TBL] [Abstract][Full Text] [Related]
40. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones. Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]